High‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with first recurrence of Ewing sarcoma

The Cochrane Library

Evidencia fiable. Decisiones informadas. Mejor salud.

Ir a:

Figure 1

Flowchart for study identification and selection

Summary of findings 1. High‐dose chemotherapy with autologous haematopoietic cell transplantation versus conventional chemotherapy

High‐dose chemotherapy with autologous haematopoietic cell transplantation versus conventional chemotherapy
Patient or population: children, adolescents, and young adults with the first recurrence of Ewing sarcoma Settings: (paediatric) oncology departments Intervention: high‐dose chemotherapy (HDC) with autologous haematopoietic cell transplantation (AHCT) Comparison: conventional chemotherapy
Outcomes	Comments
Event‐free survival	No studies included
Overall survival	No studies included
Quality‐adjusted survival	No studies included
Toxicity	No studies included
Progression‐free survival	No studies included

Summary of findings 1. High‐dose chemotherapy with autologous haematopoietic cell transplantation versus conventional chemotherapy